Including the life-time cumulative number of joint bleeds in the definition of primary prophylaxis.
den Uijl
Ingrid E M
IE
Fischer
Kathelijn
K
D003029:Coagulants / Q000008:administration & dosage / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D005169:Factor VIII / Q000008:administration & dosage / Q000627:therapeutic use*; D006395:Hemarthrosis / Q000209:etiology / Q000517:prevention & control*; D006467:Hemophilia A / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D012107:Research Design; D055502:Secondary Prevention; D013997:Time Factors
D003029:Coagulants; D005169:Factor VIII